These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22316375)

  • 1. Circulating microRNAs in cancer: diagnostic and prognostic significance.
    Zhou L; Zhao YP; Liu WJ; Dong J; Chen WY; Zhang TP; Chen G; Shu H
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):283-8. PubMed ID: 22316375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in health and disease--basic science and clinical applications.
    Osman A
    Clin Lab; 2012; 58(5-6):393-402. PubMed ID: 22783567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel tumor markers-circulating miRNA].
    Xie L; Qian XP; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):641-2. PubMed ID: 22340041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in research on circulating nucleic acids as diagnostic markers for cancer].
    Jing RR; Wang HM; Wang ZW
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):881-4. PubMed ID: 22340094
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
    Friel AM; Corcoran C; Crown J; O'Driscoll L
    Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.
    De Mattos-Arruda L; Olmos D; Tabernero J
    Future Oncol; 2011 Dec; 7(12):1385-97. PubMed ID: 22112315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients.
    Mostert B; Sieuwerts AM; Martens JW; Sleijfer S
    Expert Rev Mol Diagn; 2011 Apr; 11(3):259-75. PubMed ID: 21463236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.
    Menéndez P; Villarejo P; Padilla D; Menéndez JM; Montes JA
    J Surg Oncol; 2013 Feb; 107(2):217-20. PubMed ID: 22903548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of circulating tumor cells as prognostic markers for colon cancer.
    Meropol NJ
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):247-8. PubMed ID: 19521326
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].
    Vlasov VV; Rykova EIu; Ponomareva AA; Zaporozhchenko IA; Morozkin ES; Cherdyntseva NV; Laktionov PP
    Mol Biol (Mosk); 2015; 49(1):55-66. PubMed ID: 25916110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients.
    Zhou H; Xiao B; Zhou F; Deng H; Zhang X; Lou Y; Gong Z; Du C; Guo J
    Biomarkers; 2012 Mar; 17(2):104-10. PubMed ID: 22263628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.
    Zhao S; Liu Y; Zhang Q; Li H; Zhang M; Ma W; Zhao W; Wang J; Yang M
    Breast Cancer Res Treat; 2011 Dec; 130(3):809-16. PubMed ID: 21311967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in cancer: biomarkers, functions and therapy.
    Hayes J; Peruzzi PP; Lawler S
    Trends Mol Med; 2014 Aug; 20(8):460-9. PubMed ID: 25027972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
    Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
    Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.